Release date: May 16, 2017Author: Wang Longde, et al.Source: Chine J Cerebrovasc Dis.2017;14(4):217-224Abstract: The Global Burden of Disease Study 2013 showed that China was one of the global countries with a high exposure to stroke risk factors and about 94% of stroke burden was caused by manageable risk factors. Incidence: Chinese Monitoring Trends and Determinants in Cardiovascular Disease Project (Sino-MONICA project, 1987-1993) showed that the average age-standardized incidence of stroke in both men and women was 270 / 100,000 and 161 / 100,000, respectively. Prevalence: The National Hea...
Published: 2014 - 10 - 28
Release date: July 4, 2017Author: Chen weiweiSource: Chinese Circulation Journal.2017;32(6):521-530Abstract: The prevalence of cardiovascular risk factors in China is arising, which increased the number of patients with cardiovascular diseases. Overall, the morbidity and mortality of cardiovascular disease in China is still on the ascendant phase. By estimation, the number of patients with cardiovascular disease were 290 million, of which 13 million were stroke patients, 11 million were coronary heart disease patients, 4.5 million were heart failure patients, 5 million were pulmonary heart dis...
Published: 2014 - 10 - 28
Title: 2017 HRS/ EHRA/ ECAS/ APHRS/ SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summaryRelease date: 2017-05-12Author:  HRS,Heart Rhythm Society, EHRA,European Heart Rhythm Association, ECAS,European Cardiac Arrhythmia Society, APHRS,Asia Pacific Heart Rhythm SocietySource: J Arrhythm. 2017;33(5):369-409. Content Interpretation: On May 12, 2017, at the 38th Annual American Heart Rhythm Society (HRS 2017), the 2017 HRS/ EHRA/ ECAS/ APHRS/ SOLAECE expert consensus stat...
Published: 2018 - 01 - 09
Title: The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation.Release date: 2016-12-26Author:  STS,Society of Thoracic SurgeonsSource:  Ann Thorac Surg. 2017;103(1):329-341.Abstract: Executive Summary Surgical ablation for atrial fibrillation (AF) can be performed without additional risk of operative mortality or major morbidity, and is recommended at the time of concomitant mitral operations to restore sinus rhythm.(Class I, Level A) Surgical ablation for AF can be performed without additional operative risk of mortality o...
Published: 2018 - 01 - 09
Release date: 2017-03-02Author: AATS, American Association for Thoracic SurgerySource: J Thorac Cardiovasc Surg.2017;153(6):1330-1354Content Interpretation: The surgical treatment for atrial fibrillation (AF) is well established and performed. AF is being treated as a stand-alone procedure or concomitantly with valve, coronary bypass, or other types of cardiac surgical procedures. This document was put together to provide 10 recommendations for 7 research questions. Key consensus: 1, Catheter ablation and surgical ablation both are mature and important treatment option for AF patients who chose...
Published: 2018 - 01 - 09


  • Links
Copyright ©2005 - 2018 Beijing Med-Zenith Medical Scientific Co., Ltd. 互联网药品信息服务资格证书编号:(京)-非经营性-2017-0064